Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease

被引:0
|
作者
Sykora, Daniel [1 ]
Firth, Christine [2 ]
Girardo, Marlene [3 ]
Tseng, Andrew [4 ]
Wennberg, Paul [5 ]
Liedl, David [5 ]
Shamoun, Fadi [2 ]
机构
[1] Mayo Clin, Sch Grad Med Educ, Rochester, MN USA
[2] Mayo Clin, Dept Cardiovasc Dis, Phoenix, AZ USA
[3] Mayo Clin, Div Hlth Sci Res, Dept Biomed Stat & Informat, Scottsdale, AZ USA
[4] Mayo Clin, Dept Cardiovasc Dis, Jacksonville, FL USA
[5] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
关键词
Peripheral artery disease (PAD); lower extremity artery disease; diabetes mellitus; limb ischemia; type; 1; diabetes; 2; MORTALITY; ASSOCIATION; PREVALENCE; MANAGEMENT;
D O I
10.1024/0301-1526/a001086
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Peripheral artery disease (PAD) is a risk factor for adverse limb events (LE) and cardiovascular events (CVE) that coexists with type 1 (T1) and 2 (T2) diabetes mellitus (DM). Little is known about comparative risk of LE and CVE in T1/T2 DM patients with PAD. Patients and methods: We queried our database of 40,144 patients >= 18 years old who underwent ankle brachial index (ABI) measurement from 01/1996-02/2020. We isolated T1/T2 DM patients with PAD diagnosed by ankle brachial index (ABI; low [<1.0] or elevated [>1.4]) and retrieved demographics including glycated hemoglobin (HbA1c). Primary outcomes were LE (critical limb ischemia/vascular amputation) and CVE (myocardial infarction/ ischemic stroke). All-cause mortality was a secondary outcome. Multivariable Cox proportional regression yielded hazard ratios (HR) with 95% confidence intervals (CI) after adjusting for pertinent risk factors including age, hypertension, hyperlipidemia, smoking, and HbA1c. Results: Our study found 10,156 patients with PAD and DM (34% T1DM, 66% T2DM) with median follow-up time 34 mo (IQR 85 mo). T1DM patients were younger than T2DM (mean age 67 vs. 70 years), with higher median HbA1c (7.7 [IQR 1.9] vs. 6.7% [IQR 1.6]), and more prevalent hypertension, hyperlipidemia, CAD, and CKD. Antiplatelet and statin use was equivocal. Elevated ABI was more common in T1DM (47 vs. 28%). LE occurred in 23% and CVE in 12% patients. LE risk was higher in T1 than T2 DM patients (HR 1.58 [95% CI 1.44, 1.73], p<0.0001), but CVE and all-cause mortality were equivocal. These observations were preserved across ABI and HbA1c subgroup analyses. Conclusions: PAD patients with T1DM had a higher LE risk than those with T2DM, even after adjustment for glycemic control and pertinent risk factors, but CVE risk and all-cause mortality were equivocal. These data suggest a potential role for more intensive LE risk modification in PAD patients with T1DM, but further investigation is needed.
引用
收藏
页码:310 / 316
页数:7
相关论文
共 50 条
  • [21] Development and validation of a nomogram to predict the risk of peripheral artery disease in patients with type 2 diabetes mellitus
    Liang, Jiemei
    Song, Jiazhao
    Sun, Tiehui
    Zhang, Lanning
    Xu, Shan
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Impact of microvascular complications on the outcomes of diabetic foot in type 2 diabetic patients with documented peripheral artery disease
    Gazzaruso, Carmine
    Montalcini, Tiziana
    Gallotti, Pietro
    Ferrulli, Anna
    Massa Saluzzo, Cesare
    Pujia, Arturo
    Luzi, Livio
    Coppola, Adriana
    ENDOCRINE, 2023, 80 (01) : 71 - 78
  • [23] DIABETES AND CRITICAL LIMB ISCHEMIA: THE DEADLY DUO IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERY DISEASE
    Vrsalovic, Mislav
    Vucur, Ksenija
    ACTA CLINICA CROATICA, 2016, 55 (02) : 240 - 246
  • [24] Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients
    Zoppini, Giacomo
    Targher, Giovanni
    Chonchol, Michel
    Negri, Carlo
    Stoico, Vincenzo
    Pichiri, Isabella
    Lippi, Giuseppe
    Muggeo, Michele
    Bonora, Enzo
    ATHEROSCLEROSIS, 2010, 210 (02) : 575 - 580
  • [25] Impact of international guidelines on the management of cardiovascular risk factors in diabetic patients with peripheral arterial disease
    Margeta, C.
    Giurgea, A.
    Hammer, A.
    Schlager, O.
    Zehetmayer, S.
    Koppensteiner, R.
    Willfort-Ehringer, A.
    INTERNATIONAL ANGIOLOGY, 2009, 28 (03) : 175 - 180
  • [26] Evaluation of Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Type 2 Diabetic Patients with Longer Duration of Diabetes
    Alshammari, Nawaf A.
    Alodhayani, Abdulaziz A.
    Joy, Salini S.
    Isnani, Arthur
    Mujammami, Muhammad
    Alfadda, Assim A.
    Siddiqui, Khalid
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 3007 - 3014
  • [27] Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus The Steno Type 1 Risk Engine
    Vistisen, Dorte
    Andersen, Gregers Stig
    Hansen, Christian Stevns
    Hulman, Adam
    Henriksen, Jan Erik
    Bech-Nielsen, Henning
    Jorgensen, Marit Eika
    CIRCULATION, 2016, 133 (11) : 1058 - 1066
  • [28] Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease?
    Bosevski, M.
    Borozanov, V.
    Tosev, S.
    Georgievska-Ismail, Lj.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) : 290 - 292
  • [29] Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study
    Jurado, Jeronimo
    Ybarra, Juan
    Solanas, Pascual
    Caula, Jacint
    Gich, Ignasi
    Pou, Jose M.
    Romeo, June Hart
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2009, 21 (03): : 140 - 148
  • [30] Association between thermal threshold abnormalities and peripheral artery disease in patients with type 2 diabetes
    Sheen, Yi-Jing
    Li, Tsai-Chung
    Lin, Jiann-Liang
    Tsai, Wen-Chen
    Kao, Chuen-Der
    Bau, Cho-Tsan
    Sheu, Wayne H. -H.
    MEDICINE, 2018, 97 (51)